Risk groups
The risk group “decubitus ulcer” (ICD-10: L89.-) indicates the possibility that a particular condition – for example, disease, laboratory diagnosis, use of a drug – may be associated with the risk of micronutrient deficiency:
- Retinol
- Iron
- Selenium
- Zinc*
Therapy
For the therapy of “decubital ulcer” (ICD-10: L89.-), the following micronutrients (vital substances) are used:
- Vitamin E (tocopherols)
- Vitamin C (ascorbic acid)
- Zinc
- L-Arginine
- Total protein
The above vital substance recommendations (micronutrients) were created with the help of medical experts. All statements are supported by scientific studies with high levels of evidence. For a therapy recommendation, only clinical studies with the highest degrees of evidence (grade 1a/1b and 2a/2b) were used, which, due to their high significance, prove the therapy recommendation. These data are updated at certain intervals.
